On the public citation graph

Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis

https://doi.org/10.1016/j.ahj.2007.03.032
0 signed · 59 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ccd.10636openalex-snapshot
Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial
inferredcites →https://doi.org/10.1016/j.accreview.2003.10.042openalex-snapshot
Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery
inferredcites →https://doi.org/10.1016/j.ahj.2006.05.011openalex-snapshot
The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: Randomized controlled prospective study
inferredcites →https://doi.org/10.1016/j.amjcard.2004.03.061openalex-snapshot
Evaluation of a high-dose dexamethasone-eluting stent
inferredcites →https://doi.org/10.1016/j.amjcard.2004.08.036openalex-snapshot
Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries
inferredcites →https://doi.org/10.1016/j.amjcard.2004.10.021openalex-snapshot
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention
inferredcites →https://doi.org/10.1016/j.clinthera.2005.09.009openalex-snapshot
Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: Results of the historically controlled SESAME study
inferredcites →https://doi.org/10.1016/j.jacc.2004.10.074openalex-snapshot
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes
inferredcites →https://doi.org/10.1016/j.jacc.2004.12.012openalex-snapshot
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation
inferredcites →https://doi.org/10.1016/s0002-9149(02)02237-3openalex-snapshot
Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris
inferredcites →https://doi.org/10.1016/s0002-9149(02)03097-7openalex-snapshot
Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris
inferredcites →https://doi.org/10.1016/s0002-9149(99)00612-8openalex-snapshot
Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation
inferredcites →https://doi.org/10.1016/s0002-9149(99)00767-5openalex-snapshot
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)
inferredcites →https://doi.org/10.1016/s0142-9612(01)00297-6openalex-snapshot
Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation
inferredcites →https://doi.org/10.1016/s0735-1097(02)02562-7openalex-snapshot
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
inferredcites →https://doi.org/10.1056/nejm199101033240103openalex-snapshot
Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery Stent
inferredcites →https://doi.org/10.1056/nejm200106213442501openalex-snapshot
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
inferredcites →https://doi.org/10.1056/nejmoa035071openalex-snapshot
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
inferredcites →https://doi.org/10.1161/01.atv.0000037100.44766.5bopenalex-snapshot
Inflammation and Restenosis in the Stent Era
inferredcites →https://doi.org/10.1161/01.cir.0000096053.87580.cdopenalex-snapshot
Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction
inferredcites →https://doi.org/10.1161/01.cir.100.18.1872openalex-snapshot
Angiographic Patterns of In-Stent Restenosis
inferredcites →https://doi.org/10.1161/01.cir.101.21.2454openalex-snapshot
Edge Restenosis After Implantation of High Activity 32 P Radioactive β-Emitting Stents
inferredcites →https://doi.org/10.1161/01.cir.94.6.1247openalex-snapshot
Patterns and Mechanisms of In-Stent Restenosis
inferredcites →https://doi.org/10.1161/circulationaha.105.537878openalex-snapshot
Pathophysiology of Coronary Artery Disease
inferredcites →https://doi.org/10.1586/14779072.2.5.653openalex-snapshot
Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4625333openalex-extracted
inferred← citeshttps://doi.org/10.1002/14651858.cd004587.pub2openalex-snapshot
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
inferred← citeshttps://doi.org/10.1002/14651858.cd004587.pub3openalex-snapshot
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
inferred← citeshttps://doi.org/10.1002/14651858.cd012481.pub2openalex-snapshot
Drug-eluting stents versus bare-metal stents for acute coronary syndrome
inferred← citeshttps://doi.org/10.1002/jbm.a.34438openalex-snapshot
Covalent incorporation and controlled release of active dexamethasone from injectable polyethylene glycol hydrogels
inferred← citeshttps://doi.org/10.1002/jps.21356openalex-snapshot
Pharmaceutical aspects of drug eluting stents
inferred← citeshttps://doi.org/10.1007/978-1-4614-9434-8_17openalex-snapshot
Nanotechnology Applications in Local Arterial Drug Delivery
inferred← citeshttps://doi.org/10.1007/978-3-319-26515-5_65openalex-snapshot
Targeting Therapies to Treat Vein Graft Disease and Restenosis
inferred← citeshttps://doi.org/10.1007/s10856-011-4334-3openalex-snapshot
In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis
inferred← citeshttps://doi.org/10.1007/s11239-013-1040-7openalex-snapshot
Switching from clopidogrel to prasugrel in patients having coronary stent implantation
inferred← citeshttps://doi.org/10.1007/s12181-007-0012-6openalex-snapshot
Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES)
inferred← citeshttps://doi.org/10.1007/s12265-012-9442-zopenalex-snapshot
CYP-Mediated Pharmacologic Interference with Optimal Platelet Inhibition
inferred← citeshttps://doi.org/10.1007/s12265-013-9448-1openalex-snapshot
Pharmaco-mechanic Antithrombotic Strategies to Reperfusion of the Infarct-Related Artery in Patients with ST-Elevation Acute Myocardial Infarctions
inferred← citeshttps://doi.org/10.1007/s12265-013-9527-3openalex-snapshot
Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2011.01.002openalex-snapshot
Covalent immobilization of liposomes on plasma functionalized metallic surfaces
inferred← citeshttps://doi.org/10.1016/j.ejpb.2014.04.010openalex-snapshot
Impact of different tissue-simulating hydrogel compartments on in vitro release and distribution from drug-eluting stents
inferred← citeshttps://doi.org/10.1016/j.ijcard.2012.08.033openalex-snapshot
Dexamethasone-eluting stents had sustained favorable ischemic driven target lesion revascularization rates over 5 years: A randomized controlled prospective study
inferred← citeshttps://doi.org/10.1016/j.jcin.2012.07.015openalex-snapshot
CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome
inferred← citeshttps://doi.org/10.1016/j.jcin.2017.12.015openalex-snapshot
Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Superficial Femoral and Popliteal Artery Disease
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105637openalex-snapshot
Sustained zero-order release of dexamethasone after incorporation into crosslinked PEG-dendrons using click reactions
inferred← citeshttps://doi.org/10.1016/j.jvs.2013.10.051openalex-snapshot
Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization
inferred← citeshttps://doi.org/10.1016/j.yexcr.2010.10.006openalex-snapshot
The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression
inferred← citeshttps://doi.org/10.1097/mjt.0b013e318187de4fopenalex-snapshot
Novel Antiplatelet Agents in Development: Prasugrel, Ticagrelor, and Cangrelor and Beyond
inferred← citeshttps://doi.org/10.1101/2023.08.31.23294251openalex-snapshot
Five-year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome. A meta-analysis
inferred← citeshttps://doi.org/10.1111/bcpt.12056openalex-snapshot
Dexamethasone‐eluting Vascular Stents
inferred← citeshttps://doi.org/10.1116/1.3575530openalex-snapshot
Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers
inferred← citeshttps://doi.org/10.1177/1753944708090573openalex-snapshot
Review: Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
inferred← citeshttps://doi.org/10.14293/pr2199.000316.v1openalex-snapshot
Five-year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome. A meta-analysis.
inferred← citeshttps://doi.org/10.1517/14656566.2012.642862openalex-snapshot
Antiplatelet therapy in acute coronary syndromes
inferred← citeshttps://doi.org/10.1517/17425247.2011.572068openalex-snapshot
Stents as a platform for drug delivery
inferred← citeshttps://doi.org/10.2147/ijn.s179273openalex-snapshot
Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles
inferred← citeshttps://doi.org/10.3390/jcm12216952openalex-snapshot
Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis
inferred← citeshttps://doi.org/10.3390/polym13020292openalex-snapshot
Influence of Drug Incorporation on the Physico-Chemical Properties of Poly(l-Lactide) Implant Coating Matrices—A Systematic Study
inferred← citeshttps://doi.org/10.5402/2012/710765openalex-snapshot
Targeted Treatments for Restenosis and Vein Graft Disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.